The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 May 2019 18:02

RNS Number : 0689Y
Evraz Plc
03 May 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

EVRAZ plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

X

Other (please specify)iii: Interim distribution in specie of shares held by Crosland Global Limited to its sole shareholder as well as a sale of shares by Crosland Limited to its sole shareholder.

 

3. Details of person subject to the notification obligationiv

Name

Crosland Global Limited

City and country of registered office (if applicable)

Nicosia, Cyprus

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

 30 April 2019

6. Date on which issuer notified (DD/MM/YYYY):

02 May 2019

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.98

N/A

9.98

1,451,907,773

Position of previous notification (if

applicable)

10.04

N/A

10.04

 

       

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary share (GB00B71N6K86)

144,889,067

0

9.98

0

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

On 30 April 2019, 8,556,954 ordinary shares of EVRAZ plc were transferred out of treasury to the EVRAZ plc Employee Benefit Trust.

 

     

 

Place of completion

Nicosia, Cyprus

Date of completion

02 May 2019

 

EVRAZ Investor Relations

+7 495 232 1370

 

03 May 2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLAJMTTMBTMBAL
Date   Source Headline
28th Feb 20237:00 amEQSDISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER
27th Feb 20237:00 amEQSCLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022
28th Dec 20228:30 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
28th Dec 20227:30 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
23rd Dec 20228:30 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
23rd Dec 20227:30 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
19th Dec 202212:00 pmEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
19th Dec 202211:00 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
8th Dec 20229:17 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
8th Dec 20229:15 amEQSNOTICE OF ADJOURNED MEETING to the holders of outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer
8th Dec 20228:17 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
8th Dec 20228:16 amEQSNOTICE OF ADJOURNED MEETING to the holders of outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer
15th Nov 20228:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
15th Nov 20228:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
15th Nov 20227:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
15th Nov 20227:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
9th Nov 20221:45 pmEQSEVRAZ plc: ERNST & YOUNG TERMINATED ITS SERVICES FOR EVRAZ PLC
9th Nov 202212:46 pmEQSEVRAZ plc: ERNST & YOUNG TERMINATED ITS SERVICES FOR EVRAZ PLC
2nd Nov 20222:56 pmEQSEVRAZ plc: SANCTIONS IMPOSED ON MR. ABRAMOV AND MR. FROLOV
2nd Nov 20221:56 pmEQSEVRAZ plc: SANCTIONS IMPOSED ON MR. ABRAMOV AND MR. FROLOV
20th Oct 20227:45 pmEQSEVRAZ plc: EVRAZ SANCTIONED IN NEW ZEALAND
20th Oct 20227:45 pmEQSEVRAZ plc: EVRAZ SANCTIONED IN NEW ZEALAND
14th Oct 20224:35 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
14th Oct 20224:35 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
3rd Oct 202212:14 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
3rd Oct 202212:14 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
16th Sep 20226:45 pmEQSEVRAZ plc: UPDATE ON PAYMENT OF INTEREST DUE ON EUROBONDS ISSUED BY EVRAZ PLC
16th Sep 20226:45 pmEQSEVRAZ plc: UPDATE ON PAYMENT OF INTEREST DUE ON EUROBONDS ISSUED BY EVRAZ PLC
16th Sep 202210:24 amEQSEVRAZ plc: Changes in the composition of the Board of Directors
16th Sep 202210:24 amEQSEVRAZ plc: Changes in the composition of the Board of Directors
10th Aug 20224:00 pmEQSEVRAZ is launching soliciting of proposals for its North American subsidiaries acquisition
10th Aug 20224:00 pmEQSEVRAZ is launching soliciting of proposals for its North American subsidiaries acquisition
4th Aug 20227:39 amEQSEVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
4th Aug 20227:37 amEQSEVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
2nd Aug 20228:00 amEQSEVRAZ plc: NOTICE OF H1 2022 RESULTS AND CONFERENCE CALL DETAILS
2nd Aug 20228:00 amEQSEVRAZ plc: NOTICE OF H1 2022 RESULTS AND CONFERENCE CALL DETAILS
28th Jul 20222:33 pmEQSEVRAZ plc: Important notice to noteholders
28th Jul 20222:32 pmEQSEVRAZ plc: Important notice to noteholders
25th Jul 20224:22 pmEQSEVRAZ plc: SPECIAL LICENCE FOR EUROBONDS COUPON PAYMENTS REQUESTED
25th Jul 20224:22 pmEQSEVRAZ plc: SPECIAL LICENCE FOR EUROBONDS COUPON PAYMENTS REQUESTED
21st Jul 20226:15 pmEQSEVRAZ plc: Response to press speculations
21st Jul 20226:15 pmEQSEVRAZ plc: Response to press speculations
18th Jul 20228:39 amEQSEVRAZ plc: Termination of the registry and associated services
18th Jul 20228:38 amEQSEVRAZ plc: Termination of the registry and associated services
30th Jun 20221:55 pmEQSEVRAZ plc: Results of the Annual General Meeting
30th Jun 20221:55 pmEQSEVRAZ plc: Results of the Annual General Meeting
28th Jun 20223:45 pmEQSEVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
28th Jun 20223:45 pmEQSEVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
17th Jun 20226:57 pmEQSEVRAZ plc: EVRAZ HAS RECEIVED A SPECIAL LICENCE FROM OFSI FOR AGM2022
17th Jun 20226:57 pmEQSEVRAZ plc: EVRAZ HAS RECEIVED A SPECIAL LICENCE FROM OFSI FOR AGM2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.